Clinical Trial Update: Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

View source ↗

Summary

A terminated clinical trial exploring mechanisms and predictors of hypertension and cardiovascular disease associated with VEGF receptor inhibitors or immune ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hypertension
• Melanoma
• Renal Cell Carcinoma

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Renal Cell Carcinoma, Hypertension | Status: TERMINATED | Results posted: 2024-01-12